Latest Developments in RET-driven Thyroid Cancer

This podcast, supported by an educational grant from Eli Lilly, explores the latest developments in RET-driven thyroid cancer that were presented at the American Society of Clinical Oncology’s (ASCO) 2021 virtual conference. Hear from two experts, Dr Nicola Normanno and Dr Jonathan Wadsley, as they discuss the latest efficacy and safety data in patients with RET-driven thyroid cancer, RET testing, and the future of RET-driven diseases.